Literature DB >> 35687175

ASO Author Reflections: CEA Uptrend is a Useful Biomarker to Predict Post-Hepatectomy Survival Outcomes in Patients with Colorectal Liver Metastasis.

Yutaro Hori1, Satoru Seo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35687175     DOI： 10.1245/s10434-022-11980-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  2 in total

1.  Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.

Authors:  Yasuo Sakamoto; Yuji Miyamoto; Toru Beppu; Hidetoshi Nitta; Katsunori Imai; Hiromitsu Hayashi; Yoshifumi Baba; Naoya Yoshida; Akira Chikamoto; Hideo Baba
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

2.  Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.

Authors:  Yutaro Hori; Satoru Seo; Tomoaki Yoh; Kentaro Ueno; Koshiro Morino; Rei Toda; Takahiro Nishio; Yukinori Koyama; Ken Fukumitsu; Takamichi Ishii; Koichiro Hata; Toshihiko Masui; Kojiro Taura; Etsuro Hatano
Journal:  Ann Surg Oncol       Date:  2022-06-12       Impact factor: 4.339
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.